- Home
- EPIX vs FCO Comparison
EPIX vs FCO Comparison
Compare EPIX & FCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EPIX
- FCO
- Stock Information
- Founded
- EPIX 2009
- FCO 1991
- Country
- EPIX Canada
- FCO United Kingdom
- Employees
- EPIX N/A
- FCO N/A
- Industry
- EPIX Biotechnology: Pharmaceutical Preparations
- FCO Investment Managers
- Sector
- EPIX Health Care
- FCO Finance
- Exchange
- EPIX Nasdaq
- FCO Nasdaq
- Market Cap
- EPIX 76.8M
- FCO 80.3M
- IPO Year
- EPIX N/A
- FCO N/A
- Fundamental
- Price
- EPIX $1.72
- FCO $5.98
- Analyst Decision
- EPIX Hold
- FCO
- Analyst Count
- EPIX 3
- FCO 0
- Target Price
- EPIX $2.00
- FCO N/A
- AVG Volume (30 Days)
- EPIX 253.9K
- FCO 100.1K
- Earning Date
- EPIX 02-11-2025
- FCO 01-01-0001
- Dividend Yield
- EPIX N/A
- FCO 14.96%
- EPS Growth
- EPIX N/A
- FCO N/A
- EPS
- EPIX N/A
- FCO 0.43
- Revenue
- EPIX N/A
- FCO N/A
- Revenue This Year
- EPIX N/A
- FCO N/A
- Revenue Next Year
- EPIX N/A
- FCO N/A
- P/E Ratio
- EPIX N/A
- FCO $12.30
- Revenue Growth
- EPIX N/A
- FCO N/A
- 52 Week Low
- EPIX $1.40
- FCO $4.73
- 52 Week High
- EPIX $9.92
- FCO $6.63
- Technical
- Relative Strength Index (RSI)
- EPIX 47.93
- FCO 46.51
- Support Level
- EPIX $1.69
- FCO $5.92
- Resistance Level
- EPIX $1.83
- FCO $6.12
- Average True Range (ATR)
- EPIX 0.07
- FCO 0.10
- MACD
- EPIX 0.01
- FCO -0.01
- Stochastic Oscillator
- EPIX 57.69
- FCO 17.65
About EPIX ESSA Pharma Inc.
ESSA Pharma Inc is a pharmaceutical company. The company is focused on the development of small-molecule drugs for the treatment of castration-resistant prostate cancer. It is developing drugs that selectively block the amino-terminal domain of the androgen receptor, potentially overcoming the known AR-dependent resistance mechanisms of CRPC and providing CRPC patients with the potential for increased progression-free and overall survival.
About FCO abrdn Global Income Fund Inc.
abrdn Global Income Fund Inc is a closed-end, non-diversified management investment company. The Fund's principal investment objective is to provide high current income by investing predominantly in fixed-income securities. As a secondary investment objective, the Fund seeks capital appreciation, but only when consistent with its principal investment objective. It invests in Government Bonds & Corporate Bonds, and its investments are divided into three categories, Developed Markets, Investment Grade Developing Markets and Sub-Investment Grade Developing Markets.